U.K.’s life sciences sector dodges Labour bullet, concerns about relationship with EU remain

British biotech may have dodged a bullet with the Conservative victory, but the sector’s long-term fate, like that of the country, remains uncertain in the wake of an election that will result in a breach with the European Union. Long-term concerns include whether British biotech companies will be able to attract capital and talent, and how quickly British patients will receive access to new therapies.

The majority won by Boris Johnson’s Conservative Party in Thursday’s U.K. general election removes near-term uncertainty about Brexit. The country is poised to leave the union on Jan. 31. ...